kw.\*:(%22Chromatographie affinit%C3%A9%22)
Results 1 to 25 of 31049
Selection :
Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMAILLET, F; KAZATCHKINE, M. D; GLOTZ, D et al.Molecular immunology. 1983, Vol 20, Num 12, pp 1401-1404, issn 0161-5890Article
Internalization of Coxsackievirus A9 Is Mediated by β2-Microglobulin, Dynamin, and Arf6 but Not by Caveolin-1 or ClathrinHEIKKILÄ, Outi; SUSI, Petri; TEVALUOTO, Tuire et al.Journal of virology. 2010, Vol 84, Num 7, pp 3666-3681, issn 0022-538X, 16 p.Article
Preliminary crystallographic analysis of coxsackievirus A9SMYTH, M; HALL, J; FRY, E et al.Journal of molecular biology. 1993, Vol 230, Num 2, pp 667-669, issn 0022-2836Article
THE BINDING OF HUMAN COMPLEMENT PROTEINS C5, FACTOR B, BETA 1H AND PROPERDIN TO COMPLEMENT FRAGMENT C3B ON ZYMOSANDISCIPIO RG.1981; BIOCHEM. J. (LOND.); ISSN 0006-2936; GBR; DA. 1981; VOL. 199; NO 3; PP. 485-496; BIBL. 54 REF.Article
Dye-ligand affinity purification of human complement factor B and β2 glycoprotein IWILLIAMS, S. C; SIM, R. B.Journal of immunological methods. 1993, Vol 157, Num 1-2, pp 25-30, issn 0022-1759Article
Identification of a third component of complement-binding glycoprotein of human plateletsYU, G. H; HOLERS, V. M; SEYA, T et al.The Journal of clinical investigation. 1986, Vol 78, Num 2, pp 494-501, issn 0021-9738Article
Localisation of a group of antigenic sites in complement component C3, and identification of a new fragmentation patternFONTAINE, M; SIM, R. B.Biochimica et biophysica acta. 1984, Vol 789, Num 2, pp 119-127, issn 0006-3002Article
Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9HEIKKILÄ, Outi; SUSI, Petri; STANWAY, Glyn et al.Journal of general virology. 2009, Vol 90, pp 197-204, issn 0022-1317, 8 p., 1Article
Factors affecting virus plaque confirmation proceduresDAHLING, D. R; SULLIVAN, G; FREYBERG, R. W et al.Journal of virological methods. 1989, Vol 24, Num 1-2, pp 111-122, issn 0166-0934Article
Efficient RGD-independent entry process of coxsackievirus A9ROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Archives of virology. 1996, Vol 141, Num 10, pp 1909-1919, issn 0304-8608Article
A CASE OF COXSACKIE A9 VIRUS INFECTION WITH ORCHITISWILLEMS WR; HORNIG C; BAUER H et al.1978; J. MED. VIROL.; USA; DA. 1978; VOL. 3; NO 2; PP. 137-140; BIBL. 8 REF.Article
PURIFICATION OF HUMAN C3B INACTIVATOR BY MONOCLONAL ANTIBODY AFFINITY CHROMATOGRAPHY = PURIFICATION DE L'INHIBITEUR DU C3B HUMAIN PAR CHROMATOGRAPHIE D'AFFINITE SUR ANTICORPS MONOCLONAUXHSIUNG L; BARCLAY AN; BRANDON MR et al.1982; BIOCHEM. J. (LOND.); ISSN 0006-2936; GBR; DA. 1982; VOL. 203; NO 1; PP. 293-298; BIBL. 26 REF.Article
A combined method for rescue of modified enteroviruses by mutagenic primers, long PCR and T7 RNA polymerase-driven in vivo transcriptionHEIKKILÄ, Outi; KAINULAINEN, Markus; SUSI, Petri et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 129-133, issn 0166-0934, 5 p.Article
FREISETZUNG ZELLULAERER ENZYME WAEHREND DER VERMEHRUNG VON COXSACKIEVIRUS A9 IN FL-ZELLEN. II.ABHAENGIGKEIT DER ENZYMFREISETZUNG VON ZELLDICHTE, VIRUSKONZENTRATION, PH-WERT UND SERUMGEHALT DES INKUBATIONSMEDIUMS = LIBERATION DE L'ENZYME CELLULAIRE AU COURS DE LA MULTIPLICATION DU COXSACKIEVIRUS A9 EN CELLULES FL. II.INFLUENCE DU NOMBRE DE CELLULES, DE LA CONCENTRATION DE VIRUS, DU PH ET DE LA TENEUR EN SERUM DU MILIEU DE CULTURE SUR CETTE LIBERATIONKLOCKING R; SCHWEIZER H; SPROSSIG M et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 3-4; PP. 353-359; ABS. ANGL.; BIBL. 10REF.Article
A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virionsROIVAINEN, Merja; ALAKULPPI, Noora; YLIPAASTO, Petri et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 108-116, issn 0166-0934, 9 p.Article
Photoinactivation of three viruses by rose bengalLEWIS, A. L; WELLINGS, F. M; MARTIN, D. F et al.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 2, pp 127-137, issn 0360-1226Article
Small-scale preparation of complement components C3 and C4DODDS, A. W.Methods in enzymology. 1993, Vol 223, pp 46-61, issn 0076-6879Article
Identification of C3d receptors on Candida albicansCALDERONE, R. A; LINEHAN, L; WADSWORTH, E et al.Infection and immunity. 1988, Vol 56, Num 1, pp 252-258, issn 0019-9567Article
Naturally occuring anti-band 3 antibodies have a unique affinity for C3LUTZ, H. U; NATER, M; STAMMLER, P et al.Immunology (Oxford). 1993, Vol 80, Num 2, pp 191-196, issn 0019-2805Article
The erythrocyte as instigator of inflammation: generation of amidated C3 by erythrocyte adenosine deaminaseHOSTETTER, M. K; JOHNSON, G. M; RETSINAS, E. M et al.The Journal of clinical investigation. 1989, Vol 84, Num 2, pp 665-671, issn 0021-9738Article
STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. I. PLAQUE-FORMING ABILITY OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES.MATSUMOTO M; NAKANO M; NISHIKAWA F et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 67-76; BIBL. 15 REF.Article
Complement fragments C3b and iC3b coupled to latex induce a respiratory burst in human neutrophilsHOOGERWERF, M; WEENING, R. S; HACK, C. E et al.Molecular immunology. 1990, Vol 27, Num 2, pp 159-167, issn 0161-5890Article
Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2)MICKLEM, K. J; SIM, R. B; SIM, E et al.Biochemical journal (London. 1906). 1984, Vol 224, Num 1, pp 75-86, issn 0006-2936Article
A novel one-step oxidation of terminal epoxides to allylic aldehydesWILLIS, C. L.Tetrahedron letters. 1987, Vol 28, Num 19, pp 2175-2178, issn 0040-4039Article
The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum : correlation with the prevention of immune precipitationSTEWART, W. W; JOHNSON, A; STEWARD, M. W et al.Molecular immunology. 1990, Vol 27, Num 5, pp 423-428, issn 0161-5890Article